Abstract: The present invention deals with the certain castor polyesters that give high gloss when applied to the skin. Said ester are the reaction of the hydroxyl group of castor oil with less than one equivalent of a fatty acid then in a subsequently step the remainder of an equivalent of a diacid.

Abstract: A method for reducing the production of malodor in sulfur containing dermatological compositions by adjusting the pH of the composition to between about 6.5 to about 8.1. Also, sulfur containing dermatological compositions having a pH between about 6.5 and about 8.1.

Abstract: A method for smoking cessation therapy is described that utilizing an improved nicotine lozenge to satisfy transient craving. The lozenge contains nicotine, a nonnutritive sweetener and an absorbent excipient.

Abstract: The invention provides a system and method for synthesizing chemicals onto supports in a parallel manner to produce a combinatorial collection of compounds. The system includes a plurality of middle plates, with each middle plate defining a plurality of reaction zones arranged in a two dimensional array. The reaction zones are adapted to receive a solid support, such as a sheet of membrane, and the middle plates are stackable on each other to form a three dimensional array of reaction zones. The system also includes a pair of end plates, where the middle plates are located between the end plates, and where the end plates include an array of fluid guides corresponding to the array of reaction zones, to allow for selective routing of reagents through the reaction zones.

Abstract: The use of at least one homogeneous polyholoside in a cleansing and/or makeup remover composition for the skin and/or mucosae and/or eyes, comprising a cosmetically or dermatologically acceptable vehicle is disclosed, as is a composition for cleansing and/or removing makeup from the skin and/or mucosae and/or eyes, which comprises at least one homogeneous polyholoside.

Abstract: A preventive and/or therapeutic medicament for circadian rhythm sleep disorders such as jet lag syndrome which comprises as an active ingredient an alkylenedioxybenzene derivative represented by the following formula (I) wherein m represent an integer of from 2 to 5, and n represents an integer of from 1 to 3, such as 5-[3-[(2S)-(1,4-benzodioxan-2-yl-methyl)amino]propoxy]-1,3-benzodioxol, or a pharmaceutically acceptable salt thereof.

Abstract: The present invention relates to cosmetic applicators comprised of a sheet of porous or absorbent material which is impregnated with an oil-in-water emulsion composition. The oil-in-water emulsion compositions comprises an oil phase comprising from about 0.1% to about 5% by weight of the emulsion composition of an oil-soluble moisturizing agent, dispersed in an aqueous phase. The oil-soluble moisturizer has a mean particle size ranging from about 0.05 to about 7 microns. The oil-in-water emulsion comprises from about 0.1% to about 5% by weight of the emulsion of a surfactant and from about 0.05% to about 5% by weight of the emulsion of particulates. The viscosity of the oil-in-water emulsion composition ranges from about 1 to about 500 centipoise.

Abstract: Topically applicable cosmetic/sunscreen/dermatological compositions, well suited for improved photoprotection of human skin and/or hair against the damaging effects of UV-A and UV-B irradiation and/or for the therapeutic treatment of a disease state of the skin or mucosae, essentially in the absence of photobluing/whitening, comprise at least one titanium dioxide (nano)pigment and an effective photobluing/whitening-reducing amount of deformable hollow particulates (microspheres) having a particle size ranging from 1 .mu.m to 250 .mu.m and which comprise an expanded copolymer of vinylidene chloride, acrylonitrile and a (meth)acrylate.

Abstract: A method for determining the presence and/or concentration of a water treatment polymer in an aqueous sample, comprising producing a polyclonal or monoclonal antibody to the water treatment polymer, and using the antibody so produced as a reagent in an immunoassay, conducted on the aqueous sample.

Abstract: The invention relates to a cosmetic or dermatological composition gelled by an elastomeric organopolysiloxane which is at least partially crosslinked, combined with a fatty phase comprising at least one make-up-removing oil which is compatible with the organopolysiloxane, chosen from isohexadecane and isododecane, for removing make-up from around the eyes, more especially sensitive eyes, and containing little or no preserving agent or surfactant. The fatty phase in particular has average Hansen solubility parameters dD, dP and dH which satisfy the following three conditions:(1) dD.ltoreq.20 (J/cm.sup.3).sup.1/2(2) dP.ltoreq.10 (J/cm.sup.3).sup.1/2(3) dH.ltoreq.15 (J/cm.sup.3).sup.1/2.

Abstract: The present invention is for cosmetic compositions where upon application forms a film. The applied composition provides significant wear benefits improvement to the user. These composition comprise the combination of organosiloxane resins and fluid diorganosiloxane resins with a volatile carrier.

Abstract: The invention relates to flavor-masked pharmaceutical compositions for oral administration, their preparation and their use as medicaments.The new pharmaceutical preparations according to the invention make it possible to administer pharmaceutical active substances having very unpleasant organoleptic properties such as, for example, very bad taste, even in liquid form.

Abstract: The subject of the invention is new cosmetic compositions, based on pigment nanoparticles and on fillers, which are completely transparent and free from whitening when they are applied on the skin, which possess sufficient UV screening properties for the addition of organic screening agents to be unnecessary, which are better dispersed than the compositions of the prior art and which are outstandingly stable. These compositions, when they are used in makeup, exhibit greater homogeneity of the color and a coloring which is both transparent and more intense. The present invention also relates to methods of imparting these improved properties to makeup compositions.

Abstract: Cosmetic composition or cosmetic composition carrier comprising an aqueous microdispersion of particles containing at least one wax, the said particles being solid up to a temperature equal to at least -30.degree. C., the said particles containing, in addition, a lipophilic hydrofluorocarbon organic compound such that the proportion of the number of fluorine atoms with respect to the total number of fluorine and hydrogen atoms linked to the carbon atoms in the molecule of the said compound is equal to at least 10% and is not greater than 90%.Application of the said composition, in particular, for making up eyelashes or hair care.

Abstract: Disclosed are conjugates including a polymer backbone or microbead and binding molecules, such as Fv, Fab, or F(ab').sub.2 fragments of monoclonal antibodies or whole antibodies that are bound through their Fc carbohydrate moieties or have their Fc portion modified so that they cannot effect ADCC or complement-mediated cytolysis, and that are specific for a T cell surface antigen, such as CD3, TCR, CD4, CD8, or CD28 on T cells. The polymer or microbead is preferably made of cross-linked dextran, ficoll, latex, or agarose. The microbeads are preferably of 1 to 10 .mu.m in size, so that they can be suspended in in vivo fluids. These conjugates can be used to induce proliferation of T cells and immune stimulation, and to increase the antibody response against an administered antigen.

Abstract: An inhibitor of cholesterol synthesis is used for the treatment, alleviation or prevention of skin disorders.

Abstract: Coloured cosmetic composition containing at least one particulate filler and at least one colorant, in which at least part of the fillers of the composition is coated with a polymer combined with at least one colorant.

Abstract: The present application relates to the use, as a cosmetic product, of crosslinked and at least 90% neutralized poly(2-acrylamido-2-methylpropanesulphonic acid) polymers. They generally comprise, distributed randomly:a) from 90 to 99.9% by weight of units of general formula (1) below: ##STR1## in which X.sup.+ denotes a cation or a mixture of cations, not more than 10 mol % of the cations X.sup.+ being able to be protons H.sup.+ ;b) from 0.01 to 10% by weight of crosslinking units derived from at least one monomer having at least two olefinic double bonds; the weight proportions being defined relative to the total weight of the polymer.The present application relates in particular to their use as thickener and/or gelling agent in cosmetic and/or dermatological compositions.

Abstract: A cosmetic or dermatological composition comprising a graft copolymer having a backbone comprising a copolymer with a glass transition temperature ranging from 0 to 30.degree. C., capable of being obtained by radical polymerization or by polycondensation and comprising on the backbone chain at least one graft unit including a hydrophobic macromonomer with a glass transition temperature higher than 25.degree. C.

Abstract: The invention relates to a stable multiple phase emulsion of the O.sub.1 /W/O.sub.2 type with high proportions of the primary O.sub.1 /W emulsion. The new emulsions have an emulsifier-free primary oil-in-water phase consisting of a viscoplastic aqueous gel containing the finely distributed inner oil droplets together with a gelling agent, wherein the thixotropic primary oil-in-water phase has a yield point in the range from 20 to 100 Pa and a plastic viscosity of 0.01 to 0.1 Pa.multidot.s and contains at least one lipophilic agent in the primary oil; and a secondary oil phase in which the primary oil-in-water phase is present together with a lipophilic emulsifier; and wherein the proportion of the inner oily phase is from 10 to 35 % by weight relative to the total weight of the emulsion. The higher proportions of the inner oily phase render possible higher proportions of organic sun protection agents with simultaneous avoidance of skin irritations.